{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:28:29Z","timestamp":1789522109437,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1038\/s41375-023-01817-z","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T10:32:15Z","timestamp":1674124335000},"page":"606-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Chronic lymphocytic leukemia presence impairs antigen-specific CD8+ T-cell responses through epigenetic reprogramming towards short-lived effectors"],"prefix":"10.1038","volume":"37","author":[{"given":"Anne W. J.","family":"Martens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Kavazovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Krapi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Min","family":"Pack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Arens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8948-2549","authenticated-orcid":false,"given":"Aldo","family":"Jongejan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2357-3659","authenticated-orcid":false,"given":"Perry D.","family":"Moerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-6640","authenticated-orcid":false,"given":"Eric","family":"Eldering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerritje J. W.","family":"van der Windt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-8882","authenticated-orcid":false,"given":"Felix M.","family":"Wensveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0509-315X","authenticated-orcid":false,"given":"Fleur S.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3190-1891","authenticated-orcid":false,"given":"Arnon P.","family":"Kater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"1817_CR1","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1182\/bloodadvances.2021005083","volume":"5","author":"TE Lew","year":"2021","unstructured":"Lew TE, Lin VS, Cliff ER, Blombery P, Thompson ER, Handunnetti SM, et al. Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition. Blood Adv. 2021;5:4054\u20138.","journal-title":"Blood Adv"},{"key":"1817_CR2","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014;371:1507\u201317.","journal-title":"N Engl J Med"},{"key":"1817_CR3","doi-asserted-by":"crossref","unstructured":"Siddiqi T, Soumerai JD, Dorritie KA, Stephens DM, Riedell PA, Arnason JE, et al. Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed\/refractory CLL or SLL. Blood. 2022;139:1794\u2013806.","DOI":"10.1182\/blood.2021011895"},{"key":"1817_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","volume":"24","author":"JA Fraietta","year":"2018","unstructured":"Fraietta JA, Lacey SF, Orlando EJ, Pruteanu-Malinici I, Gohil M, Lundh S, et al. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat Med. 2018;24:563\u201371.","journal-title":"Nat Med"},{"key":"1817_CR5","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/imcb.12254","volume":"97","author":"AD McLellan","year":"2019","unstructured":"McLellan AD, Ali Hosseini Rad SM. Chimeric antigen receptor T cell persistence and memory cell formation. Immunol Cell Biol. 2019;97:664\u201374.","journal-title":"Immunol Cell Biol"},{"key":"1817_CR6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bjh.15918","volume":"186","author":"S Man","year":"2019","unstructured":"Man S, Henley P. Chronic lymphocytic leukaemia: the role of T cells in a B cell disease. Br J Haematol. 2019;186:220\u201333.","journal-title":"Br J Haematol"},{"key":"1817_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3324\/haematol.2020.267914","volume":"106","author":"FS Peters","year":"2021","unstructured":"Peters FS, Strefford JC, Eldering E, Kater AP. T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective. Haematologica. 2021;106:1234\u201343.","journal-title":"Haematologica."},{"key":"1817_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1182\/blood.2018885863","volume":"134","author":"JAC van Bruggen","year":"2019","unstructured":"van Bruggen JAC, Martens AWJ, Fraietta JA, Hofland T, Tonino SH, Eldering E, et al. Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8(+) T cells and impede CAR T-cell efficacy. Blood. 2019;134:44\u201358.","journal-title":"Blood."},{"key":"1817_CR9","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","volume":"121","author":"JC Riches","year":"2013","unstructured":"Riches JC, Davies JK, McClanahan F, Fatah R, Iqbal S, Agrawal S, et al. T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Blood. 2013;121:1612\u201321.","journal-title":"Blood."},{"key":"1817_CR10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1172\/JCI24176","volume":"115","author":"G G\u00f6rg\u00fcn","year":"2005","unstructured":"G\u00f6rg\u00fcn G, Holderried TA, Zahrieh D, Neuberg D, Gribben JG. Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J Clin Investig. 2005;115:1797\u2013805.","journal-title":"J Clin Investig"},{"key":"1817_CR11","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1073\/pnas.102181599","volume":"99","author":"R Bichi","year":"2002","unstructured":"Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R, et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA. 2002;99:6955\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1817_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","volume":"76","author":"KA Hogquist","year":"1994","unstructured":"Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T-cell receptor antagonist peptides induce positive selection. Cell. 1994;76:17\u201327.","journal-title":"Cell."},{"key":"1817_CR13","doi-asserted-by":"publisher","first-page":"e1006072","DOI":"10.1371\/journal.ppat.1006072","volume":"12","author":"I Dekhtiarenko","year":"2016","unstructured":"Dekhtiarenko I, Ratts RB, Blatnik R, Lee LN, Fischer S, Borkner L, et al. Peptide processing is critical for T-cell memory inflation and may be optimized to improve immune protection by CMV-based vaccine vectors. PLoS Pathog. 2016;12:e1006072.","journal-title":"PLoS Pathog"},{"key":"1817_CR14","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1128\/JVI.02087-09","volume":"84","author":"NA Lemmermann","year":"2010","unstructured":"Lemmermann NA, Gergely K, Bohm V, Deegen P, Daubner T, Reddehase MJ. Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes. J Virol. 2010;84:1221\u201336.","journal-title":"J Virol"},{"key":"1817_CR15","doi-asserted-by":"publisher","first-page":"e3000648","DOI":"10.1371\/journal.pbio.3000648","volume":"18","author":"I Kavazovic","year":"2020","unstructured":"Kavazovic I, Han H, Balzaretti G, Slinger E, Lemmermann NAW, Ten Brinke A, et al. Eomes broadens the scope of CD8 T-cell memory by inhibiting apoptosis in cells of low affinity. PLoS Biol. 2020;18:e3000648.","journal-title":"PLoS Biol"},{"key":"1817_CR16","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. 2017;14:959\u201362.","journal-title":"Nat Methods"},{"key":"1817_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1182\/blood-2003-01-0182","volume":"102","author":"WJ Mackus","year":"2003","unstructured":"Mackus WJ, Frakking FN, Grummels A, Gamadia LE, De Bree GJ, Hamann D, et al. Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia. Blood. 2003;102:1057\u201363.","journal-title":"Blood."},{"key":"1817_CR18","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.3389\/fimmu.2018.02692","volume":"9","author":"MD Martin","year":"2018","unstructured":"Martin MD, Badovinac VP. Defining memory CD8 T cell. Front Immunol. 2018;9:2692.","journal-title":"Front Immunol"},{"key":"1817_CR19","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s41590-020-0786-2","volume":"21","author":"MA Ataide","year":"2020","unstructured":"Ataide MA, Komander K, Knopper K, Peters AE, Wu H, Eickhoff S, et al. BATF3 programs CD8(+) T cell memory. Nat Immunol. 2020;21:1397\u2013407.","journal-title":"Nat Immunol"},{"key":"1817_CR20","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1097\/HS9.0000000000000337","volume":"4","author":"T Hofland","year":"2020","unstructured":"Hofland T, de Weerdt I, Endstra S, Jongejan A, Platenkamp L, Remmerswaal EBM, et al. Functional differences between EBV- and CMV-specific CD8(+) T cells demonstrate heterogeneity of T cell dysfunction in CLL. Hemasphere. 2020;4:e337.","journal-title":"Hemasphere"},{"key":"1817_CR21","first-page":"2427","volume":"118","author":"AG Ramsay","year":"2008","unstructured":"Ramsay AG, Johnson AJ, Lee AM, Gorgun G, Le Dieu R, Blum W, et al. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Investig. 2008;118:2427\u201337.","journal-title":"J Clin Investig"},{"key":"1817_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1182\/blood-2015-02-626754","volume":"126","author":"F McClanahan","year":"2015","unstructured":"McClanahan F, Riches JC, Miller S, Day WP, Kotsiou E, Neuberg D, et al. Mechanisms of PD-L1\/PD-1-mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Emicro-TCL1 CLL mouse model. Blood. 2015;126:212\u201321.","journal-title":"Blood."},{"key":"1817_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1182\/blood-2015-01-622936","volume":"126","author":"F McClanahan","year":"2015","unstructured":"McClanahan F, Hanna B, Miller S, Clear AJ, Lichter P, Gribben JG, et al. PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia. Blood. 2015;126:203\u201311.","journal-title":"Blood."},{"key":"1817_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-4614-6217-0_12","volume":"785","author":"D Amsen","year":"2013","unstructured":"Amsen D, Backer RA, Helbig C. Decisions on the road to memory. Adv Exp Med Biol. 2013;785:107\u201320.","journal-title":"Adv Exp Med Biol"},{"key":"1817_CR25","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1002\/eji.201546000","volume":"45","author":"C Mathieu","year":"2015","unstructured":"Mathieu C, Beltra JC, Charpentier T, Bourbonnais S, Di Santo JP, Lamarre A, et al. IL-2 and IL-15 regulate CD8+ memory T-cell differentiation but are dispensable for protective recall responses. Eur J Immunol. 2015;45:3324\u201338.","journal-title":"Eur J Immunol"},{"key":"1817_CR26","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.4049\/jimmunol.177.11.7515","volume":"177","author":"N Takemoto","year":"2006","unstructured":"Takemoto N, Intlekofer AM, Northrup JT, Wherry EJ, Reiner SL. Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J Immunol. 2006;177:7515\u20139.","journal-title":"J Immunol"},{"key":"1817_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/10428194.2019.1660972","volume":"61","author":"L Llao Cid","year":"2020","unstructured":"Llao Cid L, Hanna BS, Iskar M, Roessner PM, Ozturk S, Lichter P, et al. CD8(+) T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion. Leuk Lymphoma. 2020;61:351\u20136.","journal-title":"Leuk Lymphoma"},{"key":"1817_CR28","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","volume":"51","author":"WH Hudson","year":"2019","unstructured":"Hudson WH, Gensheimer J, Hashimoto M, Wieland A, Valanparambil RM, Li P, et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1(+) stem-like CD8(+) T cells during chronic infection. Immunity. 2019;51:1043\u201358.e4.","journal-title":"Immunity."},{"key":"1817_CR29","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/j.immuni.2021.11.004","volume":"54","author":"BS Hanna","year":"2021","unstructured":"Hanna BS, Lla\u00f3-Cid L, Iskar M, Roessner PM, Klett LC, Wong JKL, et al. Interleukin-10 receptor signaling promotes the maintenance of a PD-1(int) TCF-1(+) CD8(+) T cell population that sustains anti-tumor immunity. Immunity. 2021;54:2825\u201341.e10.","journal-title":"Immunity."},{"key":"1817_CR30","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.immuni.2016.10.028","volume":"45","author":"JP Scott-Browne","year":"2016","unstructured":"Scott-Browne JP, L\u00f3pez-Moyado IF, Trifari S, Wong V, Chavez L, Rao A, et al. Dynamic changes in chromatin accessibility occur in CD8+ T cells responding to viral infection. Immunity. 2016;45:1327\u201340.","journal-title":"Immunity."},{"key":"1817_CR31","doi-asserted-by":"crossref","unstructured":"Papavassiliou AG, Musti AM. The multifaceted output of c-Jun biological activity: focus at the junction of CD8 T cell activation and exhaustion. Cells. 2020;9:2470.","DOI":"10.3390\/cells9112470"},{"key":"1817_CR32","doi-asserted-by":"publisher","first-page":"11254","DOI":"10.1128\/JVI.00576-12","volume":"86","author":"S Zhou","year":"2012","unstructured":"Zhou S, Cerny AM, Fitzgerald KA, Kurt-Jones EA, Finberg RW. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection. J Virol. 2012;86:11254\u201365.","journal-title":"J Virol"},{"key":"1817_CR33","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.4049\/jimmunol.1300099","volume":"190","author":"F Masson","year":"2013","unstructured":"Masson F, Minnich M, Olshansky M, Bilic I, Mount AM, Kallies A, et al. Id2-mediated inhibition of E2A represses memory CD8+ T cell differentiation. J Immunol. 2013;190:4585\u201394.","journal-title":"J Immunol"},{"key":"1817_CR34","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.it.2019.10.006","volume":"40","author":"D Raghu","year":"2019","unstructured":"Raghu D, Xue HH, Mielke LA. Control of lymphocyte fate, infection, and tumor immunity by TCF-1. Trends Immunol. 2019;40:1149\u201362.","journal-title":"Trends Immunol"},{"key":"1817_CR35","doi-asserted-by":"publisher","first-page":"14113","DOI":"10.1073\/pnas.1903520116","volume":"116","author":"RR Jadhav","year":"2019","unstructured":"Jadhav RR, Im SJ, Hu B, Hashimoto M, Li P, Lin JX, et al. Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade. Proc Natl Acad Sci USA. 2019;116:14113\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1817_CR36","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.4049\/jimmunol.1201150","volume":"189","author":"X Zhou","year":"2012","unstructured":"Zhou X, Xue HH. Cutting edge: generation of memory precursors and functional memory CD8+ T cells depends on T cell factor-1 and lymphoid enhancer-binding factor-1. J Immunol. 2012;189:2722\u20136.","journal-title":"J Immunol"},{"key":"1817_CR37","doi-asserted-by":"crossref","unstructured":"Zhao X, Shan Q, Xue HH. TCF1 in T cell immunity: a broadened frontier. Nat Rev Immunol. 2022;22:147\u201357.","DOI":"10.1038\/s41577-021-00563-6"},{"key":"1817_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41590-021-01086-x","volume":"23","author":"Y Zhong","year":"2022","unstructured":"Zhong Y, Walker SK, Pritykin Y, Leslie CS, Rudensky AY, van der Veeken J. Hierarchical regulation of the resting and activated T cell epigenome by major transcription factor families. Nat Immunol. 2022;23:122\u201334.","journal-title":"Nat Immunol"},{"key":"1817_CR39","doi-asserted-by":"crossref","unstructured":"Mellinghoff SC, Robrecht S, Mayer L, Weskamm LM, Dahlke C, Gruell H, et al. SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia. Leukemia. 2022;36:562\u20135.","DOI":"10.1038\/s41375-021-01500-1"},{"key":"1817_CR40","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/blood-2021-150796","volume":"138","author":"G Itchaki","year":"2021","unstructured":"Itchaki G, Rokach L, Benjamini O, Bairey O, Sabag A, Vernitsky H, et al. Cellular immune responses to BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;138:638. Supplement 1","journal-title":"Blood."},{"key":"1817_CR41","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank CU, Haining WN, Held W, Hogan PG, Kallies A, Lugli E, et al. Defining \u2018T cell exhaustion\u2019. Nat Rev Immunol. 2019;19:665\u201374.","journal-title":"Nat Rev Immunol"},{"key":"1817_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.hoc.2013.01.002","volume":"27","author":"Y Herishanu","year":"2013","unstructured":"Herishanu Y, Katz BZ, Lipsky A, Wiestner A. Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications. Hematol Oncol Clin North Am. 2013;27:173\u2013206.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1817_CR43","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1084\/jem.177.4.925","volume":"177","author":"EA Ranheim","year":"1993","unstructured":"Ranheim EA, Kipps TJ. Activated T cells induce expression of B7\/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med. 1993;177:925\u201335.","journal-title":"J Exp Med"},{"key":"1817_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","volume":"27","author":"NS Joshi","year":"2007","unstructured":"Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, Hagman J, et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity. 2007;27:281\u201395.","journal-title":"Immunity."},{"key":"1817_CR45","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/ni.2158","volume":"12","author":"CY Yang","year":"2011","unstructured":"Yang CY, Best JA, Knell J, Yang E, Sheridan AD, Jesionek AK, et al. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets. Nat Immunol. 2011;12:1221\u20139.","journal-title":"Nat Immunol"},{"key":"1817_CR46","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/ni.2153","volume":"12","author":"Y Ji","year":"2011","unstructured":"Ji Y, Pos Z, Rao M, Klebanoff CA, Yu Z, Sukumar M, et al. Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells. Nat Immunol. 2011;12:1230\u20137.","journal-title":"Nat Immunol"},{"key":"1817_CR47","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1158\/2159-8290.CD-20-1677","volume":"11","author":"GM Chen","year":"2021","unstructured":"Chen GM, Chen C, Das RK, Gao P, Chen CH, Bandyopadhyay S, et al. Integrative bulk and single-cell profiling of premanufacture t-cell populations reveals factors mediating long-term persistence of CAR T-cell therapy. Cancer Discov. 2021;11:2186\u201399.","journal-title":"Cancer Discov"},{"key":"1817_CR48","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1073\/pnas.0511137103","volume":"103","author":"CJ Luckey","year":"2006","unstructured":"Luckey CJ, Bhattacharya D, Goldrath AW, Weissman IL, Benoist C, Mathis D. Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc Natl Acad Sci USA. 2006;103:3304\u20139.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01817-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01817-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01817-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:04:56Z","timestamp":1744157096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01817-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1817"],"URL":"https:\/\/doi.org\/10.1038\/s41375-023-01817-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1829072\/v1","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GJWvdW is an employee of Genmab. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}